Literature DB >> 8536385

Isolation and functional characterization of T cells from human sputum.

G T Pang1, R L Clancy, G E Reeves.   

Abstract

T cells play a central role in the control of inflammation in the bronchial mucosa through the elaboration of proinflammatory cytokines. This study describes a method for the isolation and cloning of T cells from sputum of adult subjects. In sputum, T cells were of a minor population (< 2% of total cells), and not all expressed activation markers for CD29 (very late antigen-1 (VLA-1)), IL-2R and HLA-DR. When cultured in the presence of rIL-2 for 7 days and then cloned by limiting dilution, the ratios of CD4+ and CD8+ T cell clones (TCC) generated reflected those of CD4+ and CD8+ T cells found in sputum. CD4+ TCC and primary CD4+ T cell populations produced a range of proinflammatory cytokines when stimulated with immobilized anti-CD3 MoAb. Analysis of mRNA messages by reverse transcriptase-polymerase chain reaction (RT-PCR) and Southern blot showed good correlation with the production of cytokine in culture supernatants. A correlation existed between the pattern of cell infiltrate in sputum and the cytokine profile.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8536385      PMCID: PMC1553391          DOI: 10.1111/j.1365-2249.1995.tb03865.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  31 in total

1.  Modulation and induction of eosinophil chemotaxis by granulocyte-macrophage colony-stimulating factor and interleukin-3.

Authors:  R A Warringa; L Koenderman; P T Kok; J Kreukniet; P L Bruijnzeel
Journal:  Blood       Date:  1991-06-15       Impact factor: 22.113

2.  Down-regulation of immune responses to inhaled antigen: studies on the mechanism of induced suppression.

Authors:  J D Sedgwick; P G Holt
Journal:  Immunology       Date:  1985-12       Impact factor: 7.397

3.  Evidence for a common mucosal immunologic system. I. Migration of B immunoblasts into intestinal, respiratory, and genital tissues.

Authors:  M R McDermott; J Bienenstock
Journal:  J Immunol       Date:  1979-05       Impact factor: 5.422

4.  Accessory cell independent proliferation of human T4 cells stimulated by immobilized monoclonal antibodies to CD3.

Authors:  T D Geppert; P E Lipsky
Journal:  J Immunol       Date:  1987-03-15       Impact factor: 5.422

5.  Appearanc of cytotoxic cells within the bronchus after local infection with herpes simplex virus.

Authors:  R Clancy; W E Rawls; S Jagannath
Journal:  J Immunol       Date:  1977-09       Impact factor: 5.422

6.  Allergen- and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production.

Authors:  P Parronchi; D Macchia; M P Piccinni; P Biswas; C Simonelli; E Maggi; M Ricci; A A Ansari; S Romagnani
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

7.  Contribution of intraperitoneal immunization to the local immune response in the respiratory tract of sheep.

Authors:  R Scicchitano; A J Husband; R L Clancy
Journal:  Immunology       Date:  1984-10       Impact factor: 7.397

8.  GM-CSF, IL-1 alpha, IL-1 beta, IL-6, IL-8, IL-10, ICAM-1 and VCAM-1 gene expression and cytokine production in human duodenal fibroblasts stimulated with lipopolysaccharide, IL-1 alpha and TNF-alpha.

Authors:  G Pang; L Couch; R Batey; R Clancy; A Cripps
Journal:  Clin Exp Immunol       Date:  1994-06       Impact factor: 4.330

9.  Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte/macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects.

Authors:  A B Kay; S Ying; V Varney; M Gaga; S R Durham; R Moqbel; A J Wardlaw; Q Hamid
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

10.  Cell-mediated immunity and antibody responses in the respiratory tract after local and systemic immunization.

Authors:  R H Waldman; C S Henney
Journal:  J Exp Med       Date:  1971-08-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.